|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/11 | |
| C12N 15/113 |
| (11) | Patento numeris | 2591103 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11736498.4 |
| Europos patento paraiškos padavimo data | 2011-07-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-05-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-08-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/043099 |
| Data | 2011-07-06 |
| (87) | Numeris | WO 2012/006372 |
| Data | 2012-01-12 |
| (30) | Numeris | Data | Šalis |
| 361780 P | 2010-07-06 | US |
| (72) |
GEALL, Andrew, US
RAMSAUER, Katrin, US
OTTEN, Gillis, US
MANDL, Christian, US
|
| (73) |
GlaxoSmithKline Biologicals SA,
Rue de l`Institut 89, 1330 Rixensart,
BE
|
| (54) | DELIVERY OF RNA TO DIFFERENT CELL TYPES |
| DELIVERY OF RNA TO DIFFERENT CELL TYPES |